Pure Global
NCT05652088

The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection

Icahn School of Medicine at Mount Sinai·ClinicalTrials.gov·procedureNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
HIV Infection
Drug/Device/Intervention
Colonoscopy
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Icahn School of Medicine at Mount Sinai
Location
New York, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2023
End date
May 31, 2024
Enrollment
8 participants
Primary outcome

Change in HIV tissue viral load

Summary

The objective of this study is to understand the effects of HIV cure strategies on the virus
 and immune cells that reside within the gastrointestinal tract. Subjects receiving therapies
 with the potential for HIV cure will undergo a colonoscopy to obtain gastrointestinal tissue
 for research assays. This study will test whether receiving these therapies will induce
 changes in the immune cells in the gastrointestinal tract and reduce the tissue-associated
 HIV viral levels.

ICD-10 classifications
HIV disease resulting in other viral infectionsHuman immunodeficiency virus [HIV] diseaseHIV disease resulting in other bacterial infectionsAcute HIV infection syndromeUnspecified human immunodeficiency virus [HIV] disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05652088
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05652088 through Pure Global AI's free database. This phase not specified trial is sponsored by Icahn School of Medicine at Mount Sinai and is currently Not yet recruiting. The study focuses on HIV Infection. Target enrollment is 8 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.